Latest Breaking News On - Reinhard kandera - Page 2 : comparemela.com

HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

HOOKIPA Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Reinhard kanderaPharma incExchange commissionCompany common stockCompensation committeeCommon stockNasdaq listing ruleHuman papillomavirusPrivate securities litigation reform act

HOOKIPA Pharma to participate in upcoming investor conferences in September

NEW YORK and VIENNA, Austria, Sept. 06, 2023 HOOKIPA Pharma Inc. , a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, today announced that.

New yorkUnited statesReinhard kanderaPharma incStanley global healthcare conferenceGlobal investment conferenceHuman papillomavirusPrivate securities litigation reform actChief financial

HOOKIPA Pharma Reports Second Quarter 2023 Financial Results and Recent Business Highlights

HOOKIPA reported positive preliminary Phase 2 data on HB-200 in combination with pembrolizumab in 1st-line setting for advanced head and neck cancerRecruitment ongoing for two Phase 1 clinical trials. -Today at 07:04 am- MarketScreener

United statesReinhard kanderaJoern aldagExchange commissionPharma incImportant note regarding the stock option exchangeDevelopment expensesAmerican society of clinical oncologyGilead sciences incChief executive officerHuman papillomavirusClinical oncologyAnnual meetingInvestigational new drugGilead sciencesFast track

HOOKIPA Pharma to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 10, 2023

HOOKIPA Pharma to Report Second Quarter 2023 Financial Results and Recent Business Highlights on August 10, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Reinhard kanderaExchange commissionPharma incReport second quarterRecent business highlightsHuman papillomavirusPrivate securities litigation reform actChief financial

Insider Buying: Hookipa Pharma Inc (NASDAQ:HOOK) CFO Acquires $10,560 00 in Stock

Hookipa Pharma Inc (NASDAQ:HOOK – Free Report) CFO Reinhard Kandera purchased 12,000 shares of Hookipa Pharma stock in a transaction that occurred on Friday, June 30th. The stock was purchased at an average price of $0.88 per share, with a total value of $10,560.00. Following the transaction, the chief financial officer now owns 28,092 shares […]

Hookipa pharmaReinhard kanderaSusquehanna international groupPharma incHookipa pharma incMirabella financial servicesVirtu financialSecurities exchange commissionFree reportExchange commissionInternational groupStreet groupSigma investmentsHookipa pharma daily